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ABSTRACT
Staphylococcus aureus (SA) is a commensal habitant of nasal cavities and skin. 
Colonization by community-acquired methicillin-resistant SA (CA-MRSA) is associated 
with infections in patients who have not been recently hospitalized. The aim of this study 
is to determine the prevalence of MRSA colonization in an outpatient population, currently 
unknown in Brazil. Three-hundred patients or caregivers from two teaching hospitals were 
included. A questionnaire was applied and nasal swabs were obtained from patients. Swabs 
were inoculated in brain heart infusion (BHI) with 2.5% NaCl and seeded in mannitol. 
Suspicious colonies were subjected to MALDI-TOF MS Microflex™ identification. 
Antimicrobial susceptibility test for oxacillin was performed for SA-positive samples by 
microdilution. Polymerase chain-reactions for detection of mecA and coA genes were 
performed for resistant samples. Data about MRSA carriers were compared with non-carriers. 
There were 127 S. aureus isolates, confirmed by MALDI-TOF. Only seven (2.3%) were 
MRSA and positive for mecA and coA genes. Factors associated with MRSA carriage were 
African ethnicity, skin diseases or antibiotic use. The majority of them were from Dermatology 
clinics. Prevalence of MRSA colonization in individuals from the community was low in 
our study (2.3%). This finding raises the hypothesis of inter-household transmission of 
SA, although we did not find any association between MRSA-colonization and the shared 
use of personal objects. Given the low prevalence of MRSA carriers observed, empirical 
antimicrobial coverage for MRSA in community-acquired infections should be not necessary.
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INTRODUCTION
Staphylococcus aureus (SA) is a human commensal and inhabits nasal cavities 
and skin. It is estimated that 30-60% of the population are transiently colonized 
and 20% carry SA persistently1,2.
Although originally a nosocomial pathogen, methicillin-resistant SA (MRSA) 
has caused community-acquired infections since the 2000s3. The first community-
acquired MRSA (CA-MRSA) report was in Australia in 1993, in local indigenous 
people, and since then outbreaks have been described in different contexts. In Brazil 
CA-MRSA was reported sporadically4-7.
CA-MRSA is associated with infections in patients with no recent history of 
hospital admission and does not appear to be related to the classic risk factors for 
MRSA colonization8. Risk factors for CA-MRSA are not well established, and 
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include: living in agglomerations, children, antibiotic use 
for less than one year, chronic skin disease, HIV infection, 
and low socioeconomic level1,9,10.
Currently the prevalence of MRSA colonization in the 
community is unknown in Brazil. 
The objective of this study was to determine the 
prevalence of MRSA-colonized individuals in a population 
from an outpatient healthcare facility.
MATERIALS AND METHODS
Outpatients and persons who accompany them at two 
hospitals were included in the study during the period 
from January to April 2017. Hospital das Clinicas (HC) 
is a tertiary-care facility and Hospital Universitario (HU) 
is a community hospital. Both are teaching facilities 
affiliated with the University of Sao Paulo, Brazil. The 
research was conducted after the approval of the Research 
Ethics Committees of both hospitals (Nº 1.887.780 and 
1.930.074). Data were consolidated and analyzed, and 
patients’ identities were confidential.
Inclusion criteria: Individuals with at least 18 years 
of age who passed the entrance doors of the outpatient 
Infectious Diseases and Dermatology Clinics at HC, 
emergency room, at both hospitals and the immunization 
center.
Exclusion criteria: history of use of long-term catheters, 
undergoing surgery or hospitalization within the last year. 
Individuals included in the study, after signing the 
consent form, answered a questionnaire on personal data; 
demographics; daily habits; sports; personal hygiene; the 
presence of pets at home; illicit drug use; family members 
living in the same household; public transport (bus, 
subway or train); trips in the last year; frequency at motels, 
gyms, swimming pools or other crowded places; history 
of diseases such as Aids, cutaneous conditions, sexually 
transmitted diseases and use of antibiotics in the last year.
The number of subjects to be included in the study was 
calculated taking into account a population of 10 million 
inhabitants, a prevalence of MRSA colonization of 2% 
in this population, a 95% confidence interval with a 5% 
variation. The sample was composed of 300 subjects, 
divided equally between the five sectors, with 60 each. 
For sample collection, swabs (COPAN Venturi 
Transystem®, COPAN Diagnostics Inc., Murrieta, 
California, USA) were used. Samples were collected from 
the anterior nares by gently rotating the swab in each nare. 
One sample was obtained from each subject. Swabs were 
initially inoculated in Brain Heart Infusion medium (BHI) 
with 2.5% NaCl to stimulate the growth of cutaneous agents, 
incubated for 24 h and then seeded on regular mannitol 
agar. Samples that converted mannitol agar to yellow 
staining were subjected to MALDI-TOF MS Microflex™ 
identification (Bruker Daltonics, Billerica, Massachusetts, 
USA). The criteria for interpreting the results were: 
scores = 2.0 were accepted for species assignment and 
scores = 1.7 and <2.0 were used for genera identification. 
SA isolates were submitted to antimicrobial susceptibility 
testing by microdilution for oxacillin11. Samples were tested 
in duplicate. Isolates identified as resistant to oxacillin were 
submitted to Polymerase Chain Reaction for mecA and coA 
genes for confirmation.
Analysis of data: individuals colonized with MRSA 
strains from the community and without hospitalization 
within the past year were compared with non-colonized 
individuals. For the analysis of the dichotomous variables, 
non-parametric chi-square test and Fisher’s exact test were 
used. Numerical variables were analyzed using the Student 
T test. Also, means and standard deviations were presented. 
Statistical analysis was performed with the Epi Info 
v3.1.3 (StatCalc Statistical Calculators).
RESULTS
Three hundred samples were collected from patients and 
accompanying persons: 61% were female and 95% were 
heterosexual. None were military in the last year; two had 
been incarcerated at some point during their lives but had 
been free for more than one year. None were intravenous 
drug users or lived in the same household as a drug user. 
Eight reported sharing a home with marijuana users, three 
with inhaled cocaine users andone with volatile product 
inhalers. Two were tobacco smokers. 
Of the 300 samples collected, 127 were positive for S. 
aureus of which seven had a MIC = 4 μg/mL (4-128) and 
were positive for coA and mecA genes.
Five of the seven MRSA isolates were collected 
from patients or persons that accompanied patients at the 
Dermatology outpatient clinic. When comparing MRSA 
carriers with non-carriers, the Dermatology unit was 
associated with MRSA colonization (OR: 10.81; 95% 
CI: 2.04 - 57.23 p: 0.0042). Other factors associated with 
MRSA carriage were: history of skin disease; skin color; 
use of motels. The use of antibiotics in the last year was a 
protective factor for colonization (Table 1). 
DISCUSSION
We found a very low prevalence of MRSA colonization 
in individuals from the community: 2.3% of the entire 
population and 5.5% among the persons colonized by S. 
aureus.
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The prevalence of MRSA causing cutaneous infections 
in patients seeking emergency services in the US varied 
widely from 15% to 74% in New York and Kansas City, 
respectively12. Over the years, the incidence of CA-
MRSA infections in the United States has increased 
from 2.5% to 39%, with clonal heterogeneity in different 
regions13-15.
A published European study involving England, France, 
Germany, Italy, Greece, Romania and Spain included 
205 cases of skin and soft tissue infections16. The mean 
prevalence of MRSA was 15.1%, with no cases in Northern 
countries and 29% in Southern countries. 
In Brazil, community-acquired MRSA cases have 
been reported in the cities of Porto Alegre, Rio de Janeiro, 
Botucatu and Bahia. All cases have in common cutaneous 
involvement and the presence of PVL toxin6,17,18. A study 
evaluated nasal carriage of MRSA19 among 250 first and 
second year students from University of Londrina, in the 
South of the country, with a prevalence of 2.5%, a similar 
result to our study. Among 148 children in a daycare center 
Table 1 - Univariate analysis of characteristics associated with methicillin-resistant Staphylococcus aureus colonization among 













Male 113 (39%) 3 (43%) 1.247 0.274-5.679 1
Heterosexual 277 (95%) 7 (100%) 0 0 1
Black ethnicity 56 (19%) 4 (57%) 5.642 1.226-25.93 0.0316
Divides room with 1 or more people 228 (78%) 5 (71%) 0.726 0.137-3.832 0.658
Has pets in general 140 (48%) 5 (71%) 2.732 0.521-14.308 0.269
Dogs 112 (38%) 4 (57%) 1 0.107-9.301 1
Use of antiseptic soaps 157 (54%) 3 (43%) 0.649 0.142-2.954 0.709
Practices sports 122 (42%) 2 (28%) 0.56 0.107-2.937 0.703
Use of Shared Objects:      
    Shaver 39 (13%) 1 (14%) 1.085 0.127-9.26 1
    Soap 155 (53%) 5 (71%) 2.225 0.425-11.657 0.455
    Bath sponge 141 (48%) 4 (57%) 1.437 0.316-6.535 0.715
In the last year:      
    Family history of surgical procedure 31 (11%) 1 (14%) 1.408 0.164-12.086 0.549
    Attended motels 20 (7%) 3 (43%) 10.237 2.142-48.9292 0.011
    Beach trips 113 (39%) 4 (57%) 2.123 0.466-9.665 0.437
    History of skin diseases 35 (12%) 3 (43%) 5.528 1.187-25.738 0.045
    History of antibiotic use 75 (26%) 5 (71%) 7.266 1.38-38.244 0.016
        Amoxicillin 41 (14%) 1 (14%) 1.024 0.120-8.729 1
        Azithromycin 15 (5%) 2 (28%) 7.413 1.327-41.407 0.053
        Sulfamethoxazole + Trimethoprin 4 (1%) 0 0 0 1
        Quinolones 10 (3%) 1 (14%) 4.716 0.517-42.952 0.232
        N/A 17 (6%) 1 (14%) 2.705 0.308-23.769 0.354
Use of public transportation 233 (80%) 7 (100%) 0 0 0.351
    Bus 167 (57%) 6 (86%) 4.526 0.538-38.079 0.245
Place of collection      
    Dermatology outpatients clinic 55 (19%) 5 (71%) 10.818 2.044-57.23 0.0042
    Emegency room - HU 59 (20%) 1 (14%) 0.661 0.078-5.597 1
    Emegency room - HC 59 (20%) 1 (14%) 0.661 0.078-5.597 1
    Dermatology outpatients clinic 60 (20%) 0 0 0 0.351
    Imunization center 60 (20%) 0 0 0 0.351
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in Northeastern Brazil, MRSA nasal carriage was 7.4%20.
A previous study from our group showed that among 
hospitalized patients in the Dermatology Unit MRSA 
carriage was 45%, of which a quarter were community-
acquired21. Among chronic dermatologic patients, 
MRSA carriage is frequent, and there may be household 
transmission explaining the colonization of the people who 
accompanied patients to the Dermatology outpatient clinic 
in our study, although we did not find a relationship with 
statistical significance between colonization by MRSA and 
the shared use of personal objects.
Other findings in our study such as black ethnicity have 
been previously described by Tosas Auguet et al.22, but we 
do not know how to explain it. History of antibiotic has been 
previously described by Gustave et al.23, who suggested 
that previous antibiotics use contributed to the increase of 
MRSA lineages in the community. The association between 
attending motels and MRSA colonization has not yet been 
described and is difficult to explain. It may be due to the 
collective environment and objects shared by multiple 
individuals. 
Due to the low prevalence of colonization found in our 
sample, we suppose that empirical coverage against MRSA, 
with drugs such as clindamycin and sulfamethoxazole-
trimethoprim (SMX-TMP) or even nasal decolonization 
with mupirocin, as recommended by the IDSA24 guideline 
can be used in patients from the community without risk 
factors, in our setting.
The IDSA guideline made the US recommends the use 
of MRSA coverage for patients with severe purulent or non-
purulent infection (patients with abscesses, signs of sepsis 
or impaired immune status), skin and soft tissue infection 
from the community. However, this recommendation is 
based on studies performed in settings different from ours, 
with high MRSA prevalence in the community. 
Our study has limitations. Our sample was obtained in 
hospitals and may not represent the community. However, 
if so, the prevalence of MRSA may be even lower than the 
one we observed. The study was carried out in two hospitals 
in the city of Sao Paulo, not allowing extrapolation of data 
to the entire State or even to other regions of the country. 
Furthermore, due to the study design, we may have included 
temporary nasal carriers. On the other hand, our sample 
was very heterogeneous, which may allow us to generalize 
our results and suggest empirical therapy for infections in 
which S. aureus is suspected. 
CONCLUSION 
Given the low prevalence of MRSA nasal carriage found 
in our study (2.3%), we believe that empirical coverage 
for MRSA is not necessary for patients with community-
acquired infections caused by Staphylococcus aureus.
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